The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicines and legal actions taken by regulatory authorities around the world. It also provides signals based on information derived from Individual Case Safety Reports (ICSRs) available in the WHO Global ICSR database, VigiBase®.

This newsletter includes two feature articles: Pilot Mobile ‘APP’ for reporting suspected adverse drug reactions launched in Burkina Faso and Zambia, and, Introducing a New Member in the WHO Programme for International Drug Monitoring (WHO PIDM): Paraguay.

Posted on the WHO website on June 2017